I agree that this site is using cookies. You can find further informations here.
X
Quittet, P.
41  results:
Search for persons X
?
1

P1632: PROSPECTIVE OBSERVATIONAL STUDY IN PATIENTS WITH IDI..:

Chèze, S. ; Quittet, P. ; Adoue, D....
HemaSphere.  6 (2022)  - p. 1513-1514 , 2022
Link: https://doi.org/10.1097/..
 
?
2

Étude observationnelle prospective sur les Patients attEint..:

Cheze, S. ; Quittet, P. ; Adoue, D....
La Revue de Médecine Interne.  43 (2022)  - p. A348 , 2022
Link: https://doi.org/10.1016/..
 
?
3

Discontinuation of tyrosine kinase inhibitor in chronic mye..:

Robin, J. B. ; Theron, A. ; Quittet, P....
Annals of Hematology.  101 (2022)  5 - p. 1015-1022 , 2022
Link: https://doi.org/10.1007/..
 
?
4

Étude observationnelle prospective sur les patients atteint..:

Cheze, S. ; Quittet, P. ; Adoue, D....
La Revue de Médecine Interne.  42 (2021)  - p. A312-A313 , 2021
Link: https://doi.org/10.1016/..
 
?
5

POOLED RESULTS OF THREE ANNUAL COHORTS FROM AN OBSERVATIONA..:

Sibon, D. ; Quittet, P. ; Borel, C....
Hematological Oncology.  37 (2019)  S2 - p. 492-492 , 2019
Link: https://doi.org/10.1002/..
 
?
6

PHASE I/II STUDY OF BRENTUXIMAB VEDOTIN IN REFRACTORY/RELAP..:

Stamatoullas, A. ; Ghesquières, H. ; Quittet, P....
Hematological Oncology.  35 (2017)  S2 - p. 423-423 , 2017
Link: https://doi.org/10.1002/..
 
?
7

Factors influencing extramedullary relapse after allogeneic..:

Vincent, L ; Ceballos, P ; Plassot, C...
Blood Cancer Journal.  5 (2015)  8 - p. e341-e341 , 2015
Link: https://doi.org/10.1038/..
 
?
8

A randomised phase II study of the efficacy, safety and cos..:

Sebban, C. ; Lefranc, A. ; Perrier, L....
European Journal of Cancer.  48 (2012)  5 - p. 713-720 , 2012
Link: https://doi.org/10.1016/..
 
?
9

PCN60 COST-EFFECTIVENESS OF PEGFILGRASTIM VERSUS FILGRASTIM..:

Perrier, L. ; Lefranc, A. ; Quittet, P....
Value in Health.  14 (2011)  3 - p. A165 , 2011
Link: https://doi.org/10.1016/..
 
?
10

Efficacité et tolérance du romiplostim (Nplate®) dans le pu..:

Khellaf, M. ; Michel, M. ; Quittet, P....
La Revue de Médecine Interne.  31 (2010)  - p. S402-S403 , 2010
Link: https://doi.org/10.1016/..
 
?
11

Membrane alterations in hereditary stomatocytosis:

Bruce, L.J. ; Flatt, J.F. ; Guizouarn, H....
Transfusion Clinique et Biologique.  17 (2010)  3 - p. 201 , 2010
Link: https://doi.org/10.1016/..
 
?
12

Romiplostim-induced erythromelalgia in a patient with idiop..:

Kluger, N. ; Bessis, D. ; Quittet, P....
British Journal of Dermatology.  161 (2009)  2 - p. 482-484 , 2009
Link: https://doi.org/10.1111/..
 
?
13

Efficacité et tolérance du romiplostim (Nplate®) chez les p..:

Khellaf, M. ; Quittet, P. ; Vialard, J.-F....
La Revue de Médecine Interne.  30 (2009)  - p. S332-S333 , 2009
Link: https://doi.org/10.1016/..
 
?
14

REVERSAL OF SYMPTOMATIC TUMORAL NARCOLEPSY, WITH NORMALIZAT..:

Dauvilliers, Y. ; Abril, B. ; Charif, M....
Neurology.  69 (2007)  12 - p. 1300-1301 , 2007
Link: https://doi.org/10.1212/..
 
?
15

Four new cases of stomatin‐deficient hereditary stomatocyto..:

Fricke, Britta ; Jarvis, Helen G. ; Reid, Cecil D. L....
British Journal of Haematology.  125 (2004)  6 - p. 796-803 , 2004
Link: https://doi.org/10.1111/..
 
1-15